- April 22, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Lovenox,Lovenox HP, Clexane, Clexane forte
Synonyms :
Clexane
Class :
Anti-coagulant, Heparin
Dosage Forms & Strengths
Multi dose vial: 100mg/ml (3 ml vial)
Prefilled syringe:30mg,40mg,60mg,80mg,100mg,120mg,150mg.
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may enhance the anticoagulant effect of Heparin
NSAIDs may enhance the anticoagulant effect of Heparin
may increase the anticoagulant effect of nonsteroidal anti-inflammatory agent
may increase the anticoagulant effect of nonsteroidal anti-inflammatory agent
may increase the anticoagulant effect of nonsteroidal anti-inflammatory agent
may increase the anticoagulant effect of nonsteroidal anti-inflammatory agent
may increase the anticoagulant effect of nonsteroidal anti-inflammatory agent
may increase the anticoagulant effect of antiplatelet agents
may increase the anticoagulant effect of antiplatelet agents
may increase the anticoagulant effect of antiplatelet agents
may increase the anticoagulant effect of antiplatelet agents
may increase the anticoagulant effect of antiplatelet agents
may have an increased anticoagulant effect when combined with Enoxaparin
may have an increased anticoagulant effect when combined with Enoxaparin
piperacillin will increase the effectiveness of enoxaparin by anticoagulation
when both drugs are combined, there may be an increased effect of enoxaparin by anticoagulation
when both drugs are combined, there may be an increased effect of enoxaparin by anticoagulation
edoxaban increases the effect of anticoagulants
hemin increases the effect of anticoagulants
it increases the toxicity of anticoagulants
anticoagulants increase the toxicity of omacetaxine
vorapaxar increases the toxicity of anticoagulants
may have an increased anticoagulant effect when combined with anticoagulants
may have an increased anticoagulant effect when combined with anticoagulants
other antiplatelet agents increase the effect of anticoagulating agents
other antiplatelet agents increase the effect of anticoagulating agents
other antiplatelet agents increase the effect of anticoagulating agents
other antiplatelet agents increase the effect of anticoagulating agents
other antiplatelet agents increase the effect of anticoagulating agents
may have an increased anticoagulant effect when combined with anticoagulants
may have an increased anticoagulant effect when combined with anticoagulants
may have an increased anticoagulant effect when combined with anticoagulants
It may enhance the risk of bleeding by affecting coagulation when combined with omega-3 carboxylic acids
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
antiplatelet agents increase the effect of anticoagulants
may increase the anticoagulation when combined with ginkgo biloba
heparins: they may increase the hyperkalemic effect of Angiotensin II Receptor Blockers
heparins: they may increase the hyperkalemic effect of Angiotensin II Receptor Blockers
heparins: they may increase the hyperkalemic effect of Angiotensin II Receptor Blockers
heparins: they may increase the hyperkalemic effect of Angiotensin II Receptor Blockers
heparins: they may increase the hyperkalemic effect of Angiotensin II Receptor Blockers
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
It may diminish the metabolism when combined with Heparins
It may diminish the metabolism when combined with Heparins
It may diminish the metabolism when combined with Heparins
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
It may enhance the risk of adverse effects when combined with Anticoagulants
reduce therapeutic effects of enoxaparin
gemcitabine, by the unspecific reactions, increases the effect of enoxaparin
the effect of enoxaparin is increased by fluorouracil with the help of an unspecific interaction mechanism
antiplatelet agents increase the effect of anticoagulation of enoxaparin
lisinopril/hydrochlorothiazide
may increase the hyperkalemic effect of Angiotensin-converting enzyme inhibitors
may have an increased anticoagulant effect when combined with Anticoagulants
may have an increased anticoagulant effect when combined with Anticoagulants
may have an increased anticoagulant effect when combined with Anticoagulants
may have an increased anticoagulant effect when combined with Anticoagulants
may have an increased anticoagulant effect when combined with Anticoagulants
bromeperidol increases the toxicity of anticoagulants
it increases the effect of anticoagulants
may enhance the nephrotoxic effect of salicylates
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with ibritumomab tiuxetan
other antiplatelet agents increase the anticoagulative effect of rivaroxaban
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may have an increased anticoagulant effect when combined with anticoagulants
may have an increased anticoagulant effect when combined with anticoagulants
may have an increased anticoagulant effect when combined with anticoagulants
may have an increasingly adverse effect when combined with deferasirox
may have an increasingly adverse effect when combined with deoxycholic acid
may decrease the therapeutic effect when combined with anticoagulants
may decrease the therapeutic effect when combined with anticoagulants
